Robotic implantation of a precise brain‑computer interface to restore communication
Official title: VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration
Run by Neuralink Corp · NCT07224256 · Data updated 2026-11-12
This project tests whether a robotically implanted Neuralink N1 brain implant can help adults with severe, irreversible speech loss from ALS, spinal cord injury, or stroke communicate again.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 22 Years to 75 Years |
| Sex | All |
| Enrollment | 6 (estimated) |
| Sponsor | Neuralink Corp Industry-sponsored |
| Locations | 1 site (Dallas, Texas) |
| Status | Recruiting |
| Started | October 3, 2025 |
| Main results expected | October 2028 |
| Study ends | October 2031 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT07224256 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with ALS, PLS, cervical spinal cord injury, stroke, or similar central speech‑pathway conditions who have severe speech impairment, impaired upper limb function, English proficiency, a stable caregiver, life expectancy of at least 12 months, and suitable MRI anatomy and surgical risk are ideal candidates.
✕Probably not a fit
People with high perioperative risk, morbid obesity (BMI > 40), uncontrolled seizures or diabetes, immunosuppression, psychiatric conditions, need for ongoing MRIs, or brain anatomy unsuitable for electrode placement are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
VOICE is an early feasibility effort to test the initial clinical safety and ability of the Neuralink N1 implant, placed by the R1 robotic inserter, to restore communication. The N1 is a skull‑mounted, wireless, rechargeable device connected to thin electrode threads that are inserted into brain speech areas by the R1 robot. Adults with central speech‑pathway neurological conditions who have severe speech production impairment and impaired upper limb function are eligible after screening, MRI review, and surgical risk assessment. The study includes surgical implantation at a single center followed by regular follow‑up to monitor safety and measure any communication gains.
Why it matters
Potential benefit: If successful, the device could restore a usable method of communication for people with severe, irreversible speech loss.
How similar studies have gone: Prior intracortical brain‑computer interface work has shown proof‑of‑concept for enabling limited communication in paralysis and ALS, but this precise robotically implanted N1/R1 approach is novel and early in human testing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Adults with diagnosis of ALS, PLS, stroke, or Spinal Cord Injury who have severe speech impairment and impaired upper limb function. * Life expectancy ≥ 12 months. * Ability to communicate in English * Presence of a stable caregiver Exclusion Criteria * Moderate to high risk for serious perioperative adverse events * Morbid obesity (Body Mass Index \> 40) * History of poorly controlled seizures or epilepsy * History of poorly controlled diabetes * Requires magnetic resonance imaging (MRI) for any ongoing medical conditions * Acquired or hereditary immunosuppression * Psychiatric or psychological disorder * Brain MRI demonstrating hemorrhage, tumor, distorted or adverse anatomy. * Any condition which, in the opinion of the Investigator, would compromise your ability to safely participate in the study or undergo the implantation procedure
Where it's running
-
The University of Texas Southwestern Medical Center
Dallas, Texas, United States Recruiting
Study contacts
- Principal investigator: Nader Pouratian, MD — University of Texas Southwestern Medical Center
- Study coordinator: Neuralink Clinical Team
- Email: voice-study@neuralink.com
- Phone: +1 (650) 250-0520
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Robotically implanted brain-computer interface for patients with severe paralysis
This study is testing a new brain implant that uses a robot to help people with severe paralysis communicate and control devices better.
-
Connexus® Brain-Computer Interface to restore communication and device control
This study will try the Connexus brain-computer interface to help people with severe loss of voluntary movement (for example from ALS, cervical spinal cord injury, or stroke) communicate and control computers.
-
Robotically implanted Neuralink N1 brain-computer interface to control external devices
This study will test whether a robotically implanted Neuralink N1 brain-computer interface can safely help people with high spinal cord injuries or ALS control computers and other external devices.
-
Robotically implanted brain chip to help control external devices
This tests a wireless, rechargeable brain implant (Neuralink N1) and a robot surgical system (R1) to help people with severe arm and hand paralysis control external devices.
-
Robotically implanted brain-computer interface for controlling devices
This study is testing a new brain implant and robot to see if they can help people with severe movement limitations control devices more easily.
-
MindEx multifocal cognitive brain‑machine interface for people with severe paralysis
This trial will test the MindEx system, which uses four tiny implanted brain chips to let people with severe paralysis control a computer or tablet with their thoughts.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.